Accuray

vorige Seite Seite 1 von 4 nächste Seite

Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care

Accuray Incorporated (Nasdaq: ARAY) announced today the unveiling of a new corporate website that reflects the company's evolution and leadership in patient-first cancer treatment innovations.

OTE0007
15.05.2018 13:37
 

Accuray wird auf der ESTRO 37 Innovationen in der Krebstherapie vorstellen, bei denen der Patient im Mittelpunkt steht

Einzigartige Hologramm-Technologie präsentiert die Vorteile von Accurays Strahlentherapiesystemen und Softwarelösungen für Patienten

OTS0159
17.04.2018 13:32
 

Study Shows CyberKnife® System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients

CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based Invasive Radiosurgery

OTE0003
29.01.2018 13:35
 

European Court of Appeal Rejects Varian's Attempt to Reverse Customer Purchase of Accuray TomoTherapy® System

Accuray Incorporated (NASDAQ: ARAY) announced today that the Court of Appeal of Nantes has rejected the appeal filed by Varian Medical Systems opposing the purchase of the Accuray TomoTherapy® System by …

OTE0004
19.10.2017 13:33
 

10-year Data Shows CyberKnife® System Provides Excellent Long-term Control of Low-Risk Prostate Cancer

First Study to Evaluate the Use of Stereotactic Body Radiation Therapy in Low-Risk Prostate Cancer 10 Years Post Treatment

OTE0003
26.09.2017 13:32
 

Accuray Showcases CyberKnife® and Radixact(TM) Systems at ASTRO 2017

Accuray Incorporated (NASDAQ: ARAY) announced today that data and first-hand experience with its advanced CyberKnife® and Radixact(TM) Systems (http://www.accuray.com/product-overview) , and unique …

OTE0010
20.09.2017 22:17
 

New Data Show TomoTherapy® System Superior to RapidArc in Achieving Local Control of Head and Neck Cancers

Prospective, Multicenter Study Supported by the French National Institute of Cancer Also Demonstrates that Treatment with the TomoTherapy Platform Resulted in a Significantly Better Cancer-Specific …

OTE0003
20.07.2017 13:32
 

IUCT Oncopole Advances Cancer Care in France with the New Accuray Radixact(TM) System

The French Cancer Institute is Building its Re-irradiation and Adaptive Radiotherapy Program Using the Latest Technology Developed by Accuray

OTE0004
20.06.2017 13:32
 

Accuray: New Data Reinforce Benefits of TomoTherapy® Platform for Mainstream Radiation Therapy Treatment Indications

Multiple Studies Presented at ESTRO 36 Demonstrate System Improves Tumor Control with Reduced Toxicities

OTE0008
11.05.2017 13:42
 

Accuray: New Data Presented at ESTRO 36 Reinforce Unmatched Versatility and Precision of the CyberKnife® System

Studies Show the System Provides Excellent Outcomes Throughout the Cancer Treatment Journey, from Primary Cases to Recurrence and Metastatic Disease

OTE0007
11.05.2017 13:32
 

Accuray to Showcase CyberKnife® and Radixact(TM) Systems at ESTRO 2017

Innovations in Hardware and Software Solutions Reinforce the Benefits of Accuray Systems in Treating a Wide Range of Cancer Cases

OTE0003
03.05.2017 13:33
 
OTE0006
02.05.2017 13:32
 

First Cancer Patients in Africa Treated with the TomoTherapy® System

Premier Algerian Cancer Center Now Provides Cancer Patients with Leading-Edge Radiation Treatments

OTE0003
11.04.2017 13:32
 
OTE0001
05.04.2017 11:02
 

Accuray Launches New Cancer Patient Websites

The Internet is one of the first places patients turn to for healthcare information after receiving a cancer diagnosis, according to the American Cancer Society.

OTE0003
02.03.2017 13:32
 
vorige Seite nächste Seite